Oruka Therapeutics (ORKA) Operating Expenses (2010 - 2024)

Oruka Therapeutics' Operating Expenses history runs 15 years deep, the most recent figure standing at $3.1 million for Q2 2024.

• In Q2 2024, Operating Expenses rose 58.24% year-over-year to $3.1 million; the TTM figure through Mar 2025 stood at $3.1 million (down 60.89% YoY), while the FY2023 annual figure was $7.3 million, down 31.14% from the prior year.
• Operating Expenses for Q2 2024 stood at $3.1 million, up from $2.5 million in the prior quarter.
• The five-year high for Operating Expenses was $5.7 million in Q4 2021, with the low at $1.3 million in Q2 2020.
• The 5-year median for Operating Expenses is $2.5 million (2022), against an average of $2.9 million.
• The sharpest annual moves came in 2020 and 2022: Operating Expenses surged 301.1% in 2020, then plunged 72.75% in 2022.
• Oruka Therapeutics' Operating Expenses stood at $5.1 million in 2020, then advanced by 10.81% to $5.7 million in 2021, then slumped by 72.75% to $1.5 million in 2022, then climbed by 2.71% to $1.6 million in 2023, then soared by 96.35% to $3.1 million in 2024.
• Business Quant data shows ORKA's Operating Expenses at $3.1 million in Q2 2024, $2.5 million in Q1 2024, and $1.6 million in Q4 2023.